MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Illumina Inc

Fermé

SecteurSoins de santé

76.39 -6.75

Résumé

Variation du prix de l'action

24h

Actuel

Min

76.13

Max

81.85

Chiffres clés

By Trading Economics

Revenu

187M

Ventes

24M

1.1B

BPA

0.86

Marge bénéficiaire

16.938

Employés

8,970

EBITDA

54M

283M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+54.96% upside

Dividendes

By Dow Jones

Prochains Résultats

1 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-8.7B

13B

Ouverture précédente

83.14

Clôture précédente

76.39

Sentiment de l'Actualité

By Acuity

58%

42%

328 / 386 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bearish Evidence

Illumina Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 mars 2025, 09:18 UTC

Actions en Tendance

Stocks to Watch Tuesday: Tesla, Oracle, Delta, Nvidia -- WSJ

10 mars 2025, 21:07 UTC

Actualités

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban -- WSJ

10 mars 2025, 20:01 UTC

Actualités

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban -- WSJ

4 mars 2025, 10:56 UTC

Actions en Tendance

Stocks to Watch Tuesday: Illumina, Nvidia, Stellantis -- WSJ

Comparaison

Variation de prix

Illumina Inc prévision

Objectif de Prix

By TipRanks

54.96% hausse

Prévisions sur 12 Mois

Moyen 126.88 USD  54.96%

Haut 190 USD

Bas 90 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

19 ratings

9

Achat

8

Maintien

2

Vente

Score Technique

By Trading Central

77.54 / 87.66Support & Résistance

Court Terme

Weak Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Bearish Evidence

Sentiment

By Acuity

328 / 386Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.